279 followers
RT @sophiemdanks: Cost-Effectiveness of Domiciliary High Flow Nasal Cannula Treatment in COPD Patients with Chronic Respiratory Failure… ht…
6 followers
RT @sophiemdanks: Cost-Effectiveness of Domiciliary High Flow Nasal Cannula Treatment in COPD Patients with Chronic Respiratory Failure… ht…
818 followers
RT @chestdrsuh: @RebDCruz. Interesting study!
476 followers
@RebDCruz. Interesting study!
606 followers
RT @sophiemdanks: Cost-Effectiveness of Domiciliary High Flow Nasal Cannula Treatment in COPD Patients with Chronic Respiratory Failure… ht…
313 followers
RT @sophiemdanks: Cost-Effectiveness of Domiciliary High Flow Nasal Cannula Treatment in COPD Patients with Chronic Respiratory Failure… ht…
2,689 followers
RT @sophiemdanks: Cost-Effectiveness of Domiciliary High Flow Nasal Cannula Treatment in COPD Patients with Chronic Respiratory Failure… ht…
546 followers
Cost-Effectiveness of Domiciliary High Flow Nasal Cannula Treatment in COPD Patients with Chronic Respiratory Failure… https://t.co/xaXUMCc6d9 #NHF #myAIRVO #Optiflow
3 followers
132 followers
Adjunkt Sabrina udgiver første europæiske studie af "omkostningseffektivteten af #HFNC behandling til KOL-patienter med kronisk respirationssvigt" i @DovePress 👏 - Tak for et godt samarbejde til Line H Storgaard og @LlerWeinreich 👍 👇 https://t.co/YVplDZWtv
4,099 followers
2,697 followers
[Article] High Flow Therapy is very likely to be a cost-effective addition to usual care for #COPD patients with chronic respiratory failure. Danish cost-effectiveness study found incremental cost-effectiveness ratio of £3605 per QALY gain. https://t.co/gJ
72 followers
RT @AalborgResearch: Domiciliary Flow Nasal Cannula treatment does not only decrease symptom burden and reduce exacerbations in patients wi…
26 followers
Domiciliary Flow Nasal Cannula treatment does not only decrease symptom burden and reduce exacerbations in patients with COPD and respiratory failure. It is also benificial to Health economics this patient group. Read more: https://t.co/t9KGWTvupM